TLPH Q1 2021 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$511,000+32.4% YoY

Gross Profit

-$529,000-103.5% margin

Operating Income

-$9M-1789.0% margin

Net Income

-$9M-1752.6% margin

EPS (Diluted)

$-1.58

QoQ Revenue Growth

-30.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$87M

Total Liabilities

$115M

Stockholders' Equity

-$27M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$511,000	$386,000	+32.4%
Gross Profit	-$529,000	-$1M	+53.0%
Operating Income	-$9M	-$16M	+42.3%
Net Income	-$9M	-$16M	+43.8%